Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-27T07:30:34.315Z Has data issue: false hasContentIssue false

Progressive bruising in an otherwise healthy child: immune thrombocytopenia purpura

Published online by Cambridge University Press:  04 March 2015

Jason D. Heiner*
Affiliation:
Division of Emergency Medicine, University of Washington, Seattle, WA
Trent L. Morgan
Affiliation:
Department of Emergency Medicine, Brooke Army Medical Center, Fort Sam Houston, TX
*
Division of Emergency Medicine, University of Washington, 1959 Northeast Pacific Street, Box 356123, Seattle, WA 98195; [email protected]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Knowledge To Practice • Des connaissances à la pratique
Copyright
Copyright © Canadian Association of Emergency Physicians 2014

References

REFERENCES

1. Cines, DB, Bussel, JB, Liebman, HA, et al. The ITP syndrome: pathogenic and clinical diversity. Blood 2009;113:6511–21, doi:10.1182/blood-2009-01-129155.CrossRefGoogle ScholarPubMed
2. Provan, D, Stasi, R, Newland, AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115:168–86, doi:10.1182/blood-2009-06-225565.CrossRefGoogle ScholarPubMed
3. Stasi, R. Pathophysiology and therapeutic options in primary immune thrombocytopenia. Blood Transfus 2011;9:262–73.Google Scholar
4. Zeller, B, Rajantie, J, Hedlund-Treutiger, I, et al. Childhood idiopathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatr 2005;94:178–84, doi:10.1080/08035250410025294.Google Scholar
5. Beck, CE, Nathan, PC, Parkin, PC, et al. Corticosteroids versus intravenous immune globulin for the treatment of acute immune thrombocytopenic purpura in children: a systematic review and meta-analysis of randomized controlled trials. J Pediatr 2005;147:521–7, doi:10.1016/j.jpeds.2005.04.032.Google Scholar